Patient-Reported Vision Improves After Ocriplasmin for Vitreomacular AdhesionPatient-Reported Vision Improves After Ocriplasmin for Vitreomacular Adhesion

Patients report meaningful improvements in vision after ocriplasmin treatment for vitreomacular adhesion (VMA), according to a pair of multicenter trials. Reuters Health Information
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Source Type: news
More News: Health | Opthalmology